Corona Remedies launched its IPO today to raise more than Rs 655 crore entirely through an offer for sale (OFS) of shares ...

Corona Remedies IPO price band is set at ₹1,008 to ₹1,062 per share. At the upper-end of the price band, the company aims to ...

The company aims to raise ₹655.37 crore from the book-building issue, which is entirely an offer for sale of 61.71 lakh ...

Corona Remedies’ Rs 655-crore IPO entered Day 2 after achieving 62% subscription on Day 1, driven largely by retail demand.

While pharma company Corona Remedies is seeing robust demand with an overall subscription of 2.89 times as of 12:24 pm, ...

Two mainboard IPOs- Wakefit Innovations and Corona Remedies- kicked-off for bidding on Monday, December 08, are cumulatively ...

A detailed look at the Wakefit Innovations and Corona Remedies IPOs, examining subscription status, pricing, potential gains, ...

The unlisted shares of Corona Remedies were trading at a premium, indicating positive listing gains despite a decline over ...

Corona Remedies IPO GMP Day 1, Subscription Status Live Updates: The initial public offering of Corona Remedies kicked off ...

The IPO of Corona Remedies opens for subscription today, giving investors a chance to participate in one of the pharma sector ...

According to Investorgain, Corona Remedies' unlisted shares are trading at a grey market premium (GMP) of Rs 290. Considering ...

Up to 35 per cent of the IPO is reserved for retail investors, 50 per cent for qualified institutional buyers (QIBs), and 15 ...